After having breakfast in the Exhibit Hall with friends and colleagues, conference guests took part in the AONN+ Navigator Networks Workshop. Attendees then convened in the Mediterranean Ballroom for Poster Award presentations and the remaining sessions of this year’s event.
Attendees were up early Saturday, and eager for another jam-packed day of learning. In addition to the multitude of insightful sessions ahead of them, many were looking forward to hearing from this year’s keynote speaker and world-class gymnast, Shannon Miller.
Day 2 of the Eighth Annual Navigation & Survivorship Conference brought the highly popular N.E.X.T. Day Tracks. These presentations provide pharmaceutical and biomedical representatives with the opportunity to share the latest medical innovations, findings, and treatments in the oncology arena. The day kicked off with a breakfast session, sponsored by Bristol-Myers Squibb, titled Caring for Your OPDIVO™ (nivolumab) Patients.
On Thursday, AONN+ welcomed more than 1,000 nurse and patient navigators to the JW Marriott, Grande Lakes, in sunny Orlando, Florida, for our Eighth Annual Navigation & Survivorship Conference. This is a much-anticipated event for our leadership and members, and this year’s conference promises to be our best yet! Over the next few days, attendees will delve into some of the hottest topics in navigation and cancer treatment.
Navigators who attended the Academy of Oncology Nurse & Patient Navigators (AONN+) 2017 West Coast Regional Meeting (WCRM) enjoyed 3 packed days of education, engagement, and energy. This year’s meeting, which took place April 27-29 in Phoenix, Arizona, brought more than 200 oncology nurse and patient navigators together for what was one of AONN+’s great events this year.
Attendees were up bright and early on Saturday morning, ready to enjoy yet another day packed with informational sessions and activities. The day began with a product theater sponsored by Genomic Health, and presented by Mary Van Cleave, BSN, RN, OCN. Her presentation, titled Harnessing the Power of Genomics, began with reminding attendees about the differences between genomics and genetics.
The morning began with a breakfast N.E.X.T. Day session sponsored by Bristol-Myers Squibb. Peg Esper, DNP, ANP-BC, AOCN, discussed Opdivo (nivolumab) therapy, which is a fully human monoclonal antibody indicated for previously treated metastatic non–small-cell lung cancer. She reviewed the CheckMate 057 study, which looked at standard-of-care therapy, docetaxel, and Opdivo.
More than 900 nurse and patient navigators converged on the Las Vegas Aria today to kick off AONN+’s Seventh Annual Navigation & Survivorship Conference! For participants, the day began with the long-awaited nurse navigation and patient navigation certification exams. These are the industry’s first certifications specifically for navigators, and AONN+ is honored to be setting the standard in this area.
After a great night out on the town, guests of AONN+’s East Coast Regional Meeting got right to work on Sunday morning. Meeting Chair Sharon Gentry, RN, MSN, CBCN, CBEC, greeted the audience with a recap of the prior day. She then provided an overview of the activities for the last day.
Page 1 of 2
Results 1 - 10 of 12
Results 1 - 10 of 12